Freiburg im Breisgau, N/A, Germany
Pfizer Manufacturing Deutschland GmbH recalls
1 recall recorded since 2018, most recently on 27 September 2017. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 27 September 2017
- Terminated
- 11 May 2020
- Reason
- Microbial Contamination of Non-Sterile Products
- Distribution
- Germany; products were packaged at the Pfizer Manufacturing Deutshland Gmbh location and then distributed to other countries. No product distributed in the United States or its territories.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0212-2018
- FOR EXPORT ONLY Atorvastatin calcium Film-Coated Tablets a) 80 mg SMT Tabs Bulk, b) 40 mg SMT G EP PR KR, c) 20 mg SMT G EP PR, d) 20 mg SMT G EP PR KR, FOR MANUFACTURING, PROCESSING OR REPACKAGING
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.